Sernova (TSE:SVA) Releases Earnings Results

Sernova (TSE:SVA) posted its quarterly earnings results on Friday. The company reported C$0.01 EPS for the quarter, FiscalAI reports.

Sernova Price Performance

SVA traded down C$0.01 during trading on Friday, hitting C$0.17. 28,762 shares of the stock traded hands, compared to its average volume of 116,062. The business has a 50 day moving average price of C$0.15 and a 200 day moving average price of C$0.16. The company has a debt-to-equity ratio of -68.92, a current ratio of 0.02 and a quick ratio of 18.11. Sernova has a twelve month low of C$0.12 and a twelve month high of C$0.23. The company has a market cap of C$57.24 million, a price-to-earnings ratio of -3.40 and a beta of -0.06.

About Sernova

Sernova Biotherapeutics is a clinical-stage company developing regenerative medicine therapeutics combining its Cell Pouch with human donor cells or stem-cell derived islet-like clusters in collaboration with Evotec to create bio-hybrid organs to treat T1D. A bio-hybrid organ is comprised of non-biomaterials, such as the Cell Pouch, integrated with living tissues to restore or enhance the function of a compromised organ. This innovative approach aims to deliver a potentially revolutionary treatment for patients with chronic diseases, initially focusing on T1D and thyroid disorders.